Lee V, Parkinson R, Zahurak M, Cope L, et al. A phase II study of guadecitabine combined with irinotecan vs regorafenib or TAS-102 in irinotecan-refractory metastatic colorectal cancer patients. Int J Cancer 2024 Feb 5. doi: 10.1002/ijc.34845.
PMID: 38312102